Controlled Three-Dimensional Tumor Microenvironments Recapitulate Phenotypic Features and Differential Drug Response in Early vs Advanced Stage Breast Cancer
Singh, Manjulata, Venkata Krishnan, Harini, Ranganathan, Supraja, Kiesel, Brian, Beumer, Jan Hendrik, Sreekumar, Sreeja, Sant, Shilpa
Published in ACS biomaterials science & engineering (12.02.2018)
Published in ACS biomaterials science & engineering (12.02.2018)
Get full text
Journal Article
Human mass balance study of TAS-102 using 14C analyzed by accelerator mass spectrometry
Lee, James J., Seraj, Jabed, Yoshida, Kenichiro, Mizuguchi, Hirokazu, Strychor, Sandra, Fiejdasz, Jillian, Faulkner, Tyeler, Parise, Robert A., Fawcett, Patrick, Pollice, Laura, Mason, Scott, Hague, Jeremy, Croft, Marie, Nugteren, James, Tedder, Charles, Sun, Weijing, Chu, Edward, Beumer, Jan Hendrik
Published in Cancer chemotherapy and pharmacology (19.01.2016)
Published in Cancer chemotherapy and pharmacology (19.01.2016)
Get full text
Journal Article
Trabectedin (ET-743, Yondelis) is a substrate for P-glycoprotein, but only high expression of P-glycoprotein confers the multidrug resistance phenotype
Beumer, Jan-Hendrik, Buckle, Tessa, Ouwehand, Mariet, Franke, Niels E F, Lopez-Lazaro, Luis, Schellens, Jan H M, Beijnen, Jos H, van Tellingen, Olaf
Published in Investigational new drugs (01.02.2007)
Published in Investigational new drugs (01.02.2007)
Get full text
Journal Article
Phase Ib trial of enzalutamide (Enza) with venetoclax (Ven) in metastatic castration-resistant prostate cancer (mCRPC)
Perimbeti, Stuthi, Jamroze, Anmbreen, Attwood, Kristopher, Farmer, Bailey, Beumer, Jan Hendrik, Bies, Robert, Levine, Ellis Glenn, Kirk, Jason, Tang, Dean, Chatta, Gurkamal S., Gopalakrishnan, Dharmesh
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
ETCTN 10366: A phase 1 study of DNA-PK inhibitor peposertib in combination with hypofractionated radiotherapy for the treatment of locally advanced pancreatic adenocarcinoma
Davis, S. Lindsey, Kasi, Anup, Dayyani, Farshid, Ocean, Allyson J., Chung, Vincent, Al Hallak, Mohammed Najeeb, Fountzilas, Christos, Hu, Junxiao, Murray, Judy, Allegra, Carmen, Gore, Steven, Beumer, Jan Hendrik, Goodman, Karyn A.
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
A phase II randomized control trial of triapine plus lutetium 177 DOTATATE versus lutetium 177 DOTATATE alone for well-differentiated somatostatin receptor-positive neuroendocrine tumors
Chauhan, Aman, Kunos, Charles, Arnold, Susanne M., Weiss, Heidi, Ivy, S. Percy, Gore, Steven, Rubinstein, Lawrence, Pelosof, Lorraine, Beumer, Jan Hendrik, Kolesar, Jill, Carson, William Edgar, Kohn, Elise C., Anthony, Lowell Brian
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
A phase I trial of elimusertib in combination with cisplatin or with cisplatin plus gemcitabine in advanced solid tumors with an emphasis on urothelial carcinoma
Leibrandt, Ryan, Frankel, Paul Henry, Beumer, Jan Hendrik, Takebe, Naoko, Yin, Ming, Emamekhoo, Hamid, Lara, Primo "Lucky" N., Gore, Steven, Parikh, Mamta
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
NCI 9938: Phase I clinical trial of ATR inhibitor berzosertib (M6620, VX-970) in combination with irinotecan in patients with advanced solid tumors
Villaruz, Liza C, Kelly, Karen, Waqar, Saiama Naheed, Davis, Elizabeth J., Shapiro, Geoffrey, LoRusso, Patricia, Dees, Elizabeth Claire, Normolle, Daniel Paul, Rhee, John C., Chu, Edward, Gore, Steven, Beumer, Jan Hendrik
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Phase 1 study of indenoisoquinoline LMP744 in adults with relapsed solid tumors and lymphomas
Ko, Brian, Chen, Alice P., Kummar, Shivaani, Hogu, Murielle, Rubinstein, Larry V., Takebe, Naoko, Piekarz, Richard, Sharon, Elad, Beumer, Jan Hendrik, Wilsker, Deborah, Ketchum, Donna, Ferry-Galow, Katherine V., Parchment, Ralph E., Holleran, Julianne L., Deppas, Joshua J., Collins, Jerry M., Johnson, Barry C., Ivy, S. Percy, Doroshow, James H., O'Sullivan Coyne, Geraldine Helen
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
A phase I study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors
Cash, Thomas, Jonus, Hunter C., Tsvetkova, Maya, Beumer, Jan Hendrik, Lee, Jasmine Y, Henry, Curtis, Aguilera, Dolly, Harvey, R. Donald, Goldsmith, Kelly C.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
A phase Ib trial of enzalutamide with venetoclax in metastatic castration-resistant prostate cancer (mCRPC)
Gopalakrishnan, Dharmesh, Kirk, Jason, Davis, John, George, Saby, Levine, Ellis Glenn, Beumer, Jan Hendrik, Appleman, Leonard Joseph, Tang, Dean, Chatta, Gurkamal S.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
ETCTN 10450: A phase I trial of peposertib and lutetium 177 DOTATATE in well-differentiated somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
Chauhan, Aman, Kolesar, Jill, Yan, Donglin, Li, Daneng, Khurana, Aman, Carson, William Edgar, Arnold, Susanne M., Gore, Steven, Rubinstein, Larry, Kohn, Elise C., Ivy, Percy, Xiao, Ying, Dewaraja, Yuni, Soares, Heloisa P., Beumer, Jan Hendrik, Konda, Bhavana, Sukrithan, Vineeth, Anthony, Lowell Brian
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article
Pharmacokinetics and RP2D analysis from ETCTN 10388: A phase I trial of triapine and lutetium Lu-177 dotatate in well-differentiated somatostatin receptor–positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
Chauhan, Aman, Christner, Susan M., Beumer, Jan Hendrik, Kunos, Charles, Khurana, Aman, El Khouli, Riham, Weiss, Heidi, Yan, Donglin, Soares, Heloisa P., Halfdanarson, Thorvardur Ragnar, Li, Daneng, Carson, William Edgar, Evers, Mark B, Ivy, Percy, Kohn, Elise C., Rubinstein, Larry, Arnold, Susanne M., Kolesar, Jill, Anthony, Lowell Brian, Konda, Bhavana
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article
Etctn 10388: A phase I trial of triapine and lutetium Lu 177 dotatate in well-differentiated somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
Chauhan, Aman, Kunos, Charles, El Khouli, Riham, Kolesar, Jill, Weiss, Heidi, Carson, William Edgar, Evers, Mark B, Kidd, Mark S., Beumer, Jan Hendrik, Arnold, Susanne M., Kohn, Elise C., Anthony, Lowell Brian
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
NSABP FB-10: Phase Ib dose-escalation trial evaluating trastuzumab emtansine (T-DM1) with neratinib (N) in women with metastatic HER2+ breast cancer (MBC)
Abraham, Jame, Puhalla, Shannon, Sikov, William M., Montero, Alberto J., Salkeni, Mohamad Adham, Razaq, Wajeeha, Beumer, Jan Hendrik, Kiesel, Brian, Buyse, Marc E., Adamson, Laura M, Srinivasan, Ashok, Pogue-Geile, Katherine L., Allegra, Carmen Joseph, Jacobs, Samuel A.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Preliminary activity of veliparib (V) in BRCA2 -mutated metastatic castration-resistant prostate cancer (mCRPC)
Pahuja, Shalu, Appleman, Leonard Joseph, Belani, Chandra Prakash, Chen, Alice, Chu, Edward, Beumer, Jan Hendrik, Puhalla, Shannon
Published in Journal of clinical oncology (01.03.2015)
Published in Journal of clinical oncology (01.03.2015)
Get full text
Journal Article
Phase I/II study of the PI3Kβ inhibitor GSK2636771 in combination with pembrolizumab (P) in patients (pts) with PD-1 refractory metastatic melanoma (MM) and PTEN loss
Tawbi, Hussein Abdul-Hassan, Peng, Weiyi, Milton, Denai, Amaria, Rodabe Navroze, Glitza, Isabella Claudia, Hwu, Wen-Jen, Patel, Sapna Pradyuman, Wong, Michael K.K., Woodman, Scott Eric, Yee, Cassian, McQuade, Jennifer Leigh, Tetzlaff, Michael T., Lazar, Alexander J., Cain, Suzanne, Burton, Elizabeth M., Beumer, Jan Hendrik, Hwu, Patrick, Davies, Michael A.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Human mass balance study of TAS-102 using (14)C analyzed by accelerator mass spectrometry
Lee, James J, Seraj, Jabed, Yoshida, Kenichiro, Mizuguchi, Hirokazu, Strychor, Sandra, Fiejdasz, Jillian, Faulkner, Tyeler, Parise, Robert A, Fawcett, Patrick, Pollice, Laura, Mason, Scott, Hague, Jeremy, Croft, Marie, Nugteren, James, Tedder, Charles, Sun, Weijing, Chu, Edward, Beumer, Jan Hendrik
Published in Cancer chemotherapy and pharmacology (01.03.2016)
Published in Cancer chemotherapy and pharmacology (01.03.2016)
Get full text
Journal Article
A phase I study of veliparib (ABT-888) in combination with weekly carboplatin and paclitaxel in advanced solid malignancies and enriched for triple-negative breast cancer (TNBC)
Pahuja, Shalu, Beumer, Jan Hendrik, Appleman, Leonard Joseph, Tawbi, Hussein Abdul-Hassan, Stoller, Ronald G., Lee, James J., Lin, Yan, Ding, Fei, Yu, Jing, Belani, Chandra Prakash, Chen, Alice P., Giranda, Vincent L., Shepherd, Stacie Peacock, Chu, Edward, Puhalla, Shannon
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article